Historical Valuation
Evotec SE (EVO) is now in the Overvalued zone, suggesting that its current forward PS ratio of 1.23 is considered Overvalued compared with the five-year average of 457.78. The fair price of Evotec SE (EVO) is between -22.98 to -7.30 according to relative valuation methord. Compared to the current price of 3.66 USD , Evotec SE is Overvalued By -150.16%.
Relative Value
Fair Zone
-22.98--7.30
Current Price：3.66
-150.16%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Evotec SE (EVO) has a current Price-to-Book (P/B) ratio of 0.60. Compared to its 3-year average P/B ratio of 1.74 , the current P/B ratio is approximately -65.27% higher. Relative to its 5-year average P/B ratio of 3.12, the current P/B ratio is about -80.71% higher. Evotec SE (EVO) has a Forward Free Cash Flow (FCF) yield of approximately -7.32%. Compared to its 3-year average FCF yield of -8.02%, the current FCF yield is approximately -8.80% lower. Relative to its 5-year average FCF yield of -4.48% , the current FCF yield is about 63.34% lower.
P/B
Median3y
1.74
Median5y
3.12
FCF Yield
Median3y
-8.02
Median5y
-4.48
Competitors Valuation Multiple
AI Analysis for EVO
The average P/S ratio for EVO competitors is -38.40, providing a benchmark for relative valuation. Evotec SE Corp (EVO.O) exhibits a P/S ratio of 1.23, which is -103.21% above the industry average. Given its robust revenue growth of -5.70%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for EVO
1Y
3Y
5Y
Market capitalization of EVO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of EVO in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is EVO currently overvalued or undervalued?
Evotec SE (EVO) is now in the Overvalued zone, suggesting that its current forward PS ratio of 1.23 is considered Overvalued compared with the five-year average of 457.78. The fair price of Evotec SE (EVO) is between -22.98 to -7.30 according to relative valuation methord. Compared to the current price of 3.66 USD , Evotec SE is Overvalued By -150.16% .
What is Evotec SE (EVO) fair value?
EVO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Evotec SE (EVO) is between -22.98 to -7.30 according to relative valuation methord.
How does EVO's valuation metrics compare to the industry average?
The average P/S ratio for EVO's competitors is -38.40, providing a benchmark for relative valuation. Evotec SE Corp (EVO) exhibits a P/S ratio of 1.23, which is -103.21% above the industry average. Given its robust revenue growth of -5.70%, this premium appears unsustainable.
What is the current P/B ratio for Evotec SE (EVO) as of Jan 10 2026?
As of Jan 10 2026, Evotec SE (EVO) has a P/B ratio of 0.60. This indicates that the market values EVO at 0.60 times its book value.
What is the current FCF Yield for Evotec SE (EVO) as of Jan 10 2026?
As of Jan 10 2026, Evotec SE (EVO) has a FCF Yield of -7.32%. This means that for every dollar of Evotec SE’s market capitalization, the company generates -7.32 cents in free cash flow.
What is the current Forward P/E ratio for Evotec SE (EVO) as of Jan 10 2026?
As of Jan 10 2026, Evotec SE (EVO) has a Forward P/E ratio of -6.23. This means the market is willing to pay $-6.23 for every dollar of Evotec SE’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Evotec SE (EVO) as of Jan 10 2026?
As of Jan 10 2026, Evotec SE (EVO) has a Forward P/S ratio of 1.23. This means the market is valuing EVO at $1.23 for every dollar of expected revenue over the next 12 months.